Se

ainsi

REFERENCES
Adams, W.H., Heotis, P.M., and Scott, W.A.
1988. Medical Status of Marshallese Accidentally
Exposed to 1954 BRAVO Fallout Radiation:
January 1985 through December 1987. BNL 52192.
P.M., and Scott, W.A. 1985 Medical Status of
Marshallese Accidentally Exposed to 1954 BRAVO
Fallout Radiation: January 1983 through December
1984. BNL 51958.
Adams, W.H., Harper, J.A., Rittmaster, R.S,,

Meissner, W.A., Werber, J., and Gelman, RS.
1983. The effect of thyroid hormone administration
uponsurvival in patients with differentiated thyroid
carcinoma. Surgery 94:978-983.
Cohen, J., Gierlowski, T.C., and Schheider, A.B.
1990. A prospective study of hyperparathyroidism
in individuals exposed to radiation in childhood. J.
Amer. Med. Assoc. 264:581-584.
Conard, R.A., Meyer, L.M., Rall, J.E., Lowery, A.,

Medical

Bach, S.A., Cannon, B., Carter, E.L., Eicher, M.,
and Hechter, H. 1958. March 1957 Medical Survey
of Rongelap and Utirik People Three Years after
Exposure to Radioactive Fallout. BNL 501 (T-119).

Adams, W.H., Fields, H.A., Engle, J.R., Hadler,
S.C. 1986. Serologic markers for hepatitis B
among Marshallese accidentally exposed to fallout
radiation in 1954. Radiat. Res. 108:74-79.

Conard, R.A., Paglia, D.E., Larsen, P.R., Sutow,
W.W., Dobyns, B.M., Robbins, J., Krotosky, W.A.,

Heotis, P.M., and Scott, W.A.

1983

Status ofMarshallese Accidentally Exposed to 1954
BRAVO Fallout Radiation: January 1980 through

December 1982. BNL 51761.

Adams, W.H., Harper, J.A., Rittmaster, R.S., and

Field, J.B., Rall, J.E., and Wolff, J. 1980. Review of
Medical Findings in a Marshallese Population
Twenty-Sic Years after Accidental Exposure to
Radioactive Fallout. BNL 51261.

Grimson, R.S. 1984. Pituitary tumors following
fallout radiation exposure. J. Amer. Med. Assoc.
252:664-666.
Amonette, R.A. and Kaplan, RJ.
1976.
Squamous-cell and basal-cell carcinomasin black
patients. J. Derm. Surg. 2(2):158-161.

Conard, R.A. Meyer, L.M., Sutow, W.W.,
Robertson, J.S., Rall, J.E., Robbins, J., Jesseph,
J.E., Deisher, J.B., Hicking, A., Lanwi, I., Gusmano,

E.A., and Eicher, M. 1967. Medical Survey of the

People of Rongelap and Utirik Islands Eleven and
Twelve Years after Exposure to Fallout Radiation

(March 1965 and March 1966). BNL 50029.

Annual Report 57-58, Atomic Bomb Casualty
Commission, 1958.

Cronkite, E.P., Bond, V.P., Conard, R.A., Shulman,
N.R., Farr, R.S., Cohn, $.H., Dunham, C.L., and

Blaisdell, R.K. and Amamoto, K., Review_of

Browning, L.E. 1955. Response of human beings
accidentally exposed to significant fallout radiation.
J. Amer. Med. Assoc. 159:430-434.

1966.

Cusick, J. 1981. Radiation-induced myelomatosis.
N. Engl. J. Med. 304:204-210.

ABCC Hematologic Studies 1947-1959, Technical
Report 25-55, Atomic Bomb Casualty
Commission, Hiroshima and Nagasaki, Japan,
Brander, A., Viikinkoski, P., Nickels, J., and
Kivisaari, L. 1989. Thyroid gland: US screening
in middle-aged women with no previous thyroid
disease. Radiology 173:507-510.

Datubo-Brown, D.D. 1991. Primary malignant skin
tumors in Nigerians. J. Nat. Med. Assn. 83(4) 345348.

Burns, J.E., Eisenhauer, E.D., Jabaley, M.E., and

Davis,

Cruse, J.M. 1980. Cellular immunedeficiency in
black patients with basal cell carcinoma. J. Surg.
Oncol. 13:129-134,

M.M.,

Hanke,

C.W.,

Zollinger,

T.W.,

Montebello, J.F., Hornback, N.B., and Norins, A.L.
1989. Skin cancerin patients with chronic radiation
dermatitis, J. Am. Acad. Dermatol. 20(4):608-616.
26

See eesaneee

Adams, W.H., Engle, J.R., Harper, J.A., Heotis,

Cady, B., Cohn, K., Rossi, R.L., Sedgwick, C.E.,

Select target paragraph3